News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Shijiazhuang No.4 Pharmaceutical (02005.HK) Injection for Unstable Angina Granted Production Registration Approval
Shijiazhuang No.4 Pharmaceutical (02005.HK) announced that it has obtained a drug production registration approval from the National Medical Products Administration for Diltiazem H...
Reset
Send
The window will close in 5 seconds
Shijiazhuang No.4 Pharmaceutical (02005.HK) Injection for Unstable Angina Granted Production Registration Approval
Close
Recommend
1
Positive
0
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

Shijiazhuang No.4 Pharmaceutical (02005.HK)  +0.060 (+2.620%)    Short selling $1.45M; Ratio 62.805%   announced that it has obtained a drug production registration approval from the National Medical Products Administration for Diltiazem Hydrochloride for Injection (10mg), classified as a Category 4 chemical drug and deemed to have passed the consistency evaluation. The drug is primarily used for the emergency treatment of supraventricular tachycardia, intraoperative abnormal hypertension, hypertensive emergencies, and unstable angina.

In addition, the Group has obtained approval from the National Medical Products Administration for Propranolol Hydrochloride Injection (5ml: 5mg and 2ml: 2mg), classified as a Category 3 chemical drug and deemed to have passed the consistency evaluation. The injection is mainly used to control supraventricular tachyarrhythmia and ventricular arrhythmia, exertional angina, and pheochromocytoma (in combination with alpha-receptor blockers to control tachycardia). The Groups Propranolol Hydrochloride active pharmaceutical ingredient has also been approved and registered by the National Medical Products Administration for use in marketed formulations. (hc/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-04 16:25.)

Related News SSY GROUP (02005.HK) 1Q26 Net Profit Up 1.6% YoY



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.